TENT5A encodes terminal nucleotidyltransferase 5A, which enables RNA binding activity; is predicted to be involved in mRNA stabilization; is predicted to act upstream of or within the response to the bacterium; and is implicated in lung non-small cell carcinoma, osteoarthritis, and osteogenesis imperfecta type 18. This evidence concerns the gene TENT5A and osteogenesis imperfecta, type 18.